BBP ETF
Virtus LifeSci Biotech Products ETF
BBP ETF Overview
BBP ETF (Virtus LifeSci Biotech Products ETF) is managed by Virtus Investment Partners with $106.0M in net assets. BBP expense ratio is 0.34%, holding 70 positions across sectors including Health Care. Inception date: 2014-12-16.
BBP performance shows a YTD return of 17.73%. The 1-year return is 52.32% and the 5-year return is 13.14%.
BBP top holdings include Crinetics Pharmaceuticals Inc Com (3.2%), Precigen Corp (2.1%), Kiniksa Pharmaceuticals Ltd (2.0%), Omeros Corp Com (1.9%), Verastem Inc (1.9%). Go to all BBP holdings, BBP sectors, or BBP dividends.
BBP can be compared against other funds. Use BBP overlap to find shared positions, or BBP vs another fund for a side-by-side view. BBP alternatives are available via the screener, along with tax-loss harvesting opportunities.